US4635643A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Assay method for the in vivo quantitative determination of mineral content in bone
Assignee: Medical College of Wisconsin Research Foundation Inc
•
Filing: 1984-10-31
•
Granted: 1987-01-13
•
Expires: 2004-10-31
Abstract
Abstract An in vivo assay for quantifying the mineral content of bone comprises placing living bone into or adjacent to the coil of a nuclear magnetic resonance (NMR) spectrometer, recording a 31 P NMR spectrum while the bone is stationary, and comparing the spectrum obtained with the NMR spectrum of a reference standard containing a known concentration of a reference compound. The assay can be used to diagnose and determine the efficacy of treatment of osteodystrophy if used in conjunction with radiographic densitometry to estimate the calcium content of the bone.
Inventors
- 👤 Charles E. Brown
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 20:00
CPC Classifications
G; G01; G01R; G01R33/00; G01R33/20; G01R33/44; G01R33/46; G01R33/4641; G01R33/465
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
116 words
A noninvasive in vivo assay of the mineral content of a bone in an animal comprises: (a) placing the part of the body of the animal containing said bone to be analyzed within the operational range of a receiver coil of a NMR spectrometer; (b) recording a 31 P NMR spectrum of the bone while keeping the bone stationary; and (c) then comparing the quantitative spectral results obtained in step (b) to the spectral results obtained with a reference standard containing a known concentration and quantity of a reference compound which responds to 31 P NMR spectroscopy in a manner similar to that of bone mineral but which does not overlap the resonance of bone material.
Claim 2
Dependent Claim
116 words
A noninvasive in vivo assay of the mineral content of a bone in an animal comprises: (a) placing the part of the body of the animal containing said bone to be analyzed within the operational range of a receiver coil of a NMR spectrometer; (b) recording a 31 P NMR spectrum of the bone while keeping the bone stationary; and (c) then comparing the quantitative spectral results obtained in step (b) to the spectral results obtained with a reference standard containing a known concentration and quantity of a reference compound which responds to 31 P NMR spectroscopy in a manner similar to that of bone mineral but which does not overlap the resonance of bone material.
Claim 3
Dependent Claim
14 words
An assay of claim 1 in which the reference compound contains PF 6 -.
Claim 4
Dependent Claim
50 words
An assay of claim 1 in which the reference standard is a sold, flexible member which contains suspended therein dispersed solid particles of a reference compound which responds to 31 P spectroscopy in a manner similar to that of bone mineral but does not overlap the resonance of bone material.
Claim 5
Dependent Claim
32 words
An assay of claim 1 in which the reference standard is a solid, flexible member which contains suspended therein dispersed solid particles of a reference compound containing the PF 6 - anion.
Claim 6
Dependent Claim
31 words
An assay of claim 1 in which the spectrum are recorded with receiver coils which surround the bone and body part and which rest on the surface of the body part.
Claim 7
Independent Claim
128 words
A method of diagnosing in vivo osteodystrophy in a living animal which comprises the steps of: (a) quantifying the mineral content in a bone in said animal by placing a part of the animal's body containing said bone within the operational range of a receiver coil of an NMR spectrometer with a reference standard which contains a reference compound which responds to 31 P NMR spectroscopy in a manner similar to bone mineral but does not overlap the resonance of bone material; (b) recording a 31 P NMR spectrum of the bone while keeping said bone stationary; and (c) estimating the calcium content of said bone employing radiographic densitometry and then comparing the results obtained with said bone with the results obtained employing radiographic densitometry with normal bone.
Claim 8
Independent Claim
128 words
A method of diagnosing in vivo osteodystrophy in a living animal which comprises the steps of: (a) quantifying the mineral content in a bone in said animal by placing a part of the animal's body containing said bone within the operational range of a receiver coil of an NMR spectrometer with a reference standard which contains a reference compound which responds to 31 P NMR spectroscopy in a manner similar to bone mineral but does not overlap the resonance of bone material; (b) recording a 31 P NMR spectrum of the bone while keeping said bone stationary; and (c) estimating the calcium content of said bone employing radiographic densitometry and then comparing the results obtained with said bone with the results obtained employing radiographic densitometry with normal bone.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-01-12 | 1990-07-14 | 1991-01-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-01-12 | 1994-07-14 | 1995-01-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-01-12 | 1998-07-14 | 1999-01-13 | $7700.00 | Window Closed / Lapsed |